Tower Research Capital (TRC)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $744K | Buy |
|
|||||
|
2025
Q2 | $361K | Sell |
|
|||||
|
2025
Q1 | $710K | Sell |
|
|||||
|
2024
Q4 | $1.44M | Buy |
|
|||||
|
2024
Q3 | $260K | Sell |
|
|||||
|
2024
Q2 | $368K | Sell |
|
|||||
|
2024
Q1 | $868K | Sell |
|
|||||
|
2023
Q4 | $1.86M | Buy |
|
|||||
|
2023
Q3 | $1.16M | Sell |
|
|||||
|
2023
Q2 | $1.13M | Buy |
|
|||||
|
2023
Q1 | $603K | Buy |
|
|||||
|
2022
Q4 | $341K | Sell |
|
|||||
|
2022
Q3 | $523K | Sell |
|
|||||
|
2022
Q2 | $1.48M | Buy |
|
|||||
|
2022
Q1 | $1.02M | Sell |
|
|||||
|
2021
Q4 | $1.2M | Buy |
|
|||||
|
2021
Q3 | $598K | Sell |
|
|||||
|
2021
Q2 | $1.69M | Buy |
|
|||||
|
2021
Q1 | $1.34M | Buy |
|
|||||
|
2020
Q4 | $1.28M | Buy |
|
|||||
|
2020
Q3 | $284K | Buy |
|
|||||
|
2020
Q2 | $48K | Buy |
|
|||||
|
2020
Q1 | $6K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $35K | Sell |
|
|||||
|
2019
Q2 | $51K | Buy |
|
|||||
|
2019
Q1 | $31K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $20K | Buy |
|
|||||
|
2018
Q2 | $10K | Sell |
|
|||||
|
2018
Q1 | $299K | Buy |
|
|||||
|
2017
Q4 | $11K | Buy |
|
|||||
|
2017
Q3 | $2K | Sell |
|
|||||
|
2017
Q2 | $14K | Buy |
|
|||||
|
2017
Q1 | $5K | Buy |
|
|||||
|
2016
Q4 | $2K | Sell |
|
|||||
|
2016
Q3 | $12K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $43K | Sell |
|
|||||
|
2015
Q4 | $65K | Buy |
|
|||||
|
2015
Q3 | $16K | Sell |
|
|||||
|
2015
Q2 | $126K | Sell |
|
|||||
|
2015
Q1 | $105K | Buy |
|
|||||
|
2014
Q4 | $49K | Buy |
|
|||||
|
2014
Q3 | $17K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $10K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $51K | Buy |
|
|||||
|
2013
Q2 | $52K | Buy |
|